The safety and efficacy of laparoscopic rectal surgery with endoscopic surgery support robot (da Vinci): National Clinical Database analysis

The safety and efficacy of laparoscopic rectal surgery with endoscopic surgery support robot (da Vinci): National Clinical Database analysis - NCD_RoRecS

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041517

Enrollment

10700

Registered

2020-10-01

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who have undergone conventional laparoscopic or robot-assisted low anterior resection between January 1, 2018 and December 31, 2019, and who are enrolled in NCD 2) Patients registered as "C20 malignant neoplasm of rectum <tumor>" 3) Including patients who received preoperative radiation therapy and chemotherapy 4) Any age

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Proportion of the conversion to open surgery	—

Secondary

Measure	Time frame
1) Incidence of postoperative complications within 30 days after surgery (CD classification grade II or more) 2) Incidence of postoperative complications within 30 days after surgery 3) Incidence of reoperation/ readmission within 30 days after surgery 4) Mortality/ in-hospital mortality within 30 days after surgery 5) Surgical outcomes (Estimate blood loss, Total operative time, etc.) 6) Incidence of intraoperative adverse effects 7) Incidence of intraoperative organ injury 8) Postoperative recovery (Length of postoperative hospital stay, etc.) 9) Learning curve of robot-assisted surgery 10) Perioperative outcomes of robot-assisted surgery for rectal malignancies	—

Measure

Time frame

1) Incidence of postoperative complications within 30 days after surgery (CD classification grade II or more) 2) Incidence of postoperative complications within 30 days after surgery 3) Incidence of reoperation/ readmission within 30 days after surgery 4) Mortality/ in-hospital mortality within 30 days after surgery 5) Surgical outcomes (Estimate blood loss, Total operative time, etc.) 6) Incidence of intraoperative adverse effects 7) Incidence of intraoperative organ injury 8) Postoperative recovery (Length of postoperative hospital stay, etc.) 9) Learning curve of robot-assisted surgery 10) Perioperative outcomes of robot-assisted surgery for rectal malignancies

—

Countries

Japan

Contacts

Public ContactTakatoshi Matsuyama

Tokyo Medical and Dental University Graduate School of Medicine Department of Gastrointestinal Surgery

matsuyama.srg1@tmd.ac.jp03-5803-5254

Outcome results